Rasmussen TH, Schikora-Rustad S, Lorentzen ÅR, Tran TT, Øverås MH, Myhr KM, Wergeland S, Aarseth J, Bø L, Berge T, Høgestøl EA, Harbo HF, Tveter AT, Jørgensen KK, Cunen C, Torkildsen Ø, Holmøy T, Celius EG, Vaage JT, Nygaard GO, Lund-Johansen F, König M (2026)
Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study
BMJ Neurol Open, 8 (1), e001556
DOI 10.1136/bmjno-2026-001556, PubMed 41835014

Corona A, Clarelli F, Pääkkönen K, Harroud A, Shchetynsky K, Zollo A, Mingione A, Sorosina M, Mascia E, Giordano A, Rocca MA, Piehl F, Stridh P, Hemmer B, Goris A, Dubois B, Søndergaard HB, Sellebjerg F, D'alfonso S, Harbo HF, Olsson T, Saarela J, Priori A, Filippi M, Kockum I et al. (2026)
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study
Mult Scler, 13524585261417130 (in press)
DOI 10.1177/13524585261417130, PubMed 41776383

Helland GB, Beyer MK, Enriquez BAB, Ihle-Hansen H, Ihle-Hansen H, Andersson S, Leonardsen EH, Stangeland H, Ùjhelyi B, Hagberg G, Harbo HF, Aamodt AH, Høgestøl EA (2024)
Lesion Volume as a Predictor for Return to Work After Endovascular Treatment: A 4-Year Prospective Cohort Study
Stroke Vasc Interv Neurol, 4 (6), e001494
DOI 10.1161/SVIN.124.001494, PubMed 41583404